References

Adimora, G.N. and I.O. Odetunde, 2007. Perinatal mortality in University of Nigeria Teaching Hospital Enugu at the end of the last millennium. Niger. J. Clin. Pract., 10: 19-23.
PubMed  |  

Ahlfors, C.E., S.B. Amin and A.E. Parker, 2009. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J. Perinatol., 29: 305-309.
CrossRef  |  Direct Link  |  

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia, 2004. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 114: 297-316.
CrossRef  |  PubMed  |  Direct Link  |  

Ariel, A.S. and E. Mazzi, 2008. Exchange transfusion in infants with extreme hyperbilirubinemia: An experience from a developing country. Acta Pediatrica, 97: 754-758.
CrossRef  |  

Badie, Z., 2007. Exchange transfusion in neonatal hyperbilirubinemia : Experience in Isfahan Iran. Singapore Med. J., 48: 421-423.
PubMed  |  

Bhutani, V.K., L.H. Johnson and R. Keren, 2004. Diagnosis and management of hyperbilirubinemia in the term neonate for a safer first week. Pediatr. Clin. North Am., 51: 843-861.
CrossRef  |  PubMed  |  

Bulbul, A., F.F. Okan, E.K. Unsur and A. Nuhoglu, 2011. Adverse events associated with exchange transfusion and etiology of severe hyperbilirubinemia in near-term and term newborns Turk. J. Med. Sci., 41: 93-100.
CrossRef  |  

Calligaris, S.D., C. Bellarosa, P. Giraudi, R.P. Wennberg, J.D. Ostrow and C. Tiribelli, 2007. Cytotoxicity is predicted by unbound and not total bilirubin concentration. Pediatr. Res., 62: 576-580.
PubMed  |  

Ebbesen, F., C. Andersson, H. Verder, C. Grytter, L. Pedersen-Bjergaard, J.R. Petersen and J. Schaarup, 2005. Extreme hyperbilirubinemia in term and near term neonates in Denmark. Acta Pediatr., 94: 59-64.
PubMed  |  

Gourley, G.R., B.L. Kreamer and M. Cohnen, 1997. Inhibition of betaglucuronidase by casein hydrolysate formula. J. Pediatr. Gastroenterol. Nutr., 25: 267-272.
PubMed  |  

Ibekwe, R.C., M.U. Ibekwe and V.U. Muoneke, 2012. Outcome of exchange blood transfusion done for neonatal jaundice in Abakaliki, Southeast Nigeria. J. Clin. Neonatol., 1: 34-37.
CrossRef  |  

Ip, S., M. Chung, J. Kulig, R. O'Brien and R. Sege et al., 2004. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics, 114: e130-e153.
Direct Link  |  

Kapplan, M. and C. Hammerman, 2004. Understanding and preventing severe neonatal bilirubinemia: Is bilirubin neurotoxicity really a concern in the developed world? Clin. Perinatol., 31: 555-575.
PubMed  |  

Maisels, M.J. and A.F. McDonagh, 2008. Phototherapy for neonatal jaundice. N. Engl. J. Med., 358: 920-928.
CrossRef  |  

Mazzi, E., 2005. Hyperbilirubinemia neonatal. Rev. Soc. Bol. Ped., 44: 26-35.

Olusanya, B.O., A.A. Akande, A. Emokpae and S.A. Olowe, 2009. Infants with severe neonatal jaundice in Lagos, Nigeria: Incidence, correlates and hearing screening outcomes. Trop. Med. Int. Health, 14: 301-310.
CrossRef  |  

Owa, J.A. and T.A. Ogunlesi, 2009. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J. Pediatr., 5: 51-55.
CrossRef  |  

Randev, S. and N. Grover, 2010. Predicting neonatal hyperbilirubinemia using first day serum bilirubin levels. Indian J. Pediatr., 77: 147-150.
CrossRef  |  

Sagro, M., D. Campbell and V. Shah, 2006. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ, 175: 587-590.
CrossRef  |  

Shapiro, S.M., 2005. Definition of clinical spectrum of kernicterus and bilirubin induced neurologic dysfunction (BIND). J. Perinatol., 25: 54-59.
PubMed  |  

Smitherman, H., A.R. Stark and V.K. Bhutani, 2006. Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin. Fetal. Neonatal. Med., 11: 214-224.
PubMed  |  

Steiner, L.A., M.J. Bizzarro, R.A. Ehrenkranz and P.G. Gallagher, 2007. A decline in the frequency of neonatal exchange transfusions and its effect on exchange related morbidity and mortality. Pediatrics, 120: 27-32.
PubMed  |  Direct Link  |